2023 Q4 Form 10-K Financial Statement
#000095017024039494 Filed on April 01, 2024
Income Statement
Concept | 2023 Q4 | 2023 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | ||
YoY Change | ||
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $221.9K | $1.186M |
YoY Change | -1.54% | 20.77% |
Operating Profit | -$1.186M | |
YoY Change | 20.77% | |
Interest Expense | $1.098M | $7.771M |
YoY Change | -46.4% | 116.34% |
% of Operating Profit | ||
Other Income/Expense, Net | $550.3K | $8.154M |
YoY Change | -46.43% | -24.28% |
Pretax Income | $1.426M | $6.968M |
YoY Change | -49.96% | -28.8% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | $1.426M | $6.968M |
YoY Change | -49.96% | -28.8% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | $0.09 | $0.30 |
COMMON SHARES | ||
Basic Shares Outstanding | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q4 | 2023 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $320.1K | $320.1K |
YoY Change | 11.13% | 11.13% |
Cash & Equivalents | $0.00 | |
Short-Term Investments | ||
Other Short-Term Assets | $26.48K | $26.48K |
YoY Change | -94.41% | -94.41% |
Inventory | ||
Prepaid Expenses | $26.48K | |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $346.6K | $346.6K |
YoY Change | -54.52% | -54.51% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $83.85M | $83.85M |
YoY Change | -62.75% | -62.75% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% |
Total Long-Term Assets | $83.85M | $83.85M |
YoY Change | -62.75% | -62.75% |
TOTAL ASSETS | ||
Total Short-Term Assets | $346.6K | $346.6K |
Total Long-Term Assets | $83.85M | $83.85M |
Total Assets | $84.20M | $84.20M |
YoY Change | -62.72% | -62.72% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $27.80K | $27.80K |
YoY Change | -75.44% | -75.44% |
Accrued Expenses | $546.0K | $546.0K |
YoY Change | 17.92% | 17.91% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $1.500M |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $2.074M | $2.074M |
YoY Change | 259.89% | 259.89% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $550.3K | $550.3K |
YoY Change | -31.82% | -31.82% |
Total Long-Term Liabilities | $550.3K | $550.3K |
YoY Change | -31.82% | -31.82% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $2.074M | $2.074M |
Total Long-Term Liabilities | $550.3K | $550.3K |
Total Liabilities | $5.624M | $5.624M |
YoY Change | -37.92% | -37.92% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$5.278M | |
YoY Change | -36.21% | |
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$5.277M | $78.58M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $84.20M | $84.20M |
YoY Change | -62.72% | -62.72% |
Cashflow Statement
Concept | 2023 Q4 | 2023 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $1.426M | $6.968M |
YoY Change | -49.96% | -28.8% |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | -$147.9K | -$717.9K |
YoY Change | 276.05% | -66.14% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$379.5K | $149.0M |
YoY Change | -167.27% | |
Cash From Investing Activities | -$379.5K | $149.0M |
YoY Change | -167.27% | |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | $149.8M | |
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 519.5K | -148.3M |
YoY Change | -166.25% | |
NET CHANGE | ||
Cash From Operating Activities | -147.9K | -717.9K |
Cash From Investing Activities | -379.5K | 149.0M |
Cash From Financing Activities | 519.5K | -148.3M |
Net Change In Cash | -7.940K | 32.06K |
YoY Change | -79.82% | -79.47% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$147.9K | -$717.9K |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001852061 | |
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q4 | us-gaap |
Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#RelatedPartyMember | |
CY2022Q4 | us-gaap |
Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#RelatedPartyMember | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2023Q4 | us-gaap |
Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#RelatedPartyMember | |
CY2022Q4 | us-gaap |
Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#RelatedPartyMember | |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
001-41239 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
GENERATION ASIA I ACQUISITION LIMITED | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
E9 | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
98-1588665 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
Boundary Hall | |
CY2023 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Cricket Square | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Grand Cayman | |
CY2023 | dei |
Entity Address Country
EntityAddressCountry
|
KY | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
KY1-1102 | |
CY2023 | dei |
City Area Code
CityAreaCode
|
345 | |
CY2023 | dei |
Local Phone Number
LocalPhoneNumber
|
814-5580 | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2023 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
true | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
230703600 | |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
5395 | |
CY2023 | dei |
Auditor Name
AuditorName
|
Marcum Asia CPAs LLP | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
New York, NY | |
CY2023Q4 | us-gaap |
Cash
Cash
|
320144 | |
CY2022Q4 | us-gaap |
Cash
Cash
|
288081 | |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
26481 | |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
473993 | |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
346625 | |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
762074 | |
CY2022Q4 | us-gaap |
Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
|
22882 | |
CY2023Q4 | gaq |
Investments Held In Trust Account Noncurrent
InvestmentsHeldInTrustAccountNoncurrent
|
83854821 | |
CY2022Q4 | gaq |
Investments Held In Trust Account Noncurrent
InvestmentsHeldInTrustAccountNoncurrent
|
225084808 | |
CY2023Q4 | us-gaap |
Assets
Assets
|
84201446 | |
CY2022Q4 | us-gaap |
Assets
Assets
|
225869764 | |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
546000 | |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
463045 | |
CY2023Q4 | gaq |
Promissory Note Related Party
PromissoryNoteRelatedParty
|
1500000 | |
CY2023Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
27801 | |
CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
113184 | |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2073801 | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
576229 | |
CY2023Q4 | gaq |
Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
|
550320 | |
CY2022Q4 | gaq |
Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
|
807136 | |
CY2023Q4 | gaq |
Deferred Underwriting Commissions
DeferredUnderwritingCommissions
|
3000000 | |
CY2022Q4 | gaq |
Deferred Underwriting Commissions
DeferredUnderwritingCommissions
|
7675500 | |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
5624121 | |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
9058865 | |
CY2023Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
|
7699729 | |
CY2023Q4 | us-gaap |
Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
|
10.89 | |
CY2022Q4 | us-gaap |
Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
|
21930000 | |
CY2022Q4 | us-gaap |
Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
|
10.26 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2023Q4 | us-gaap |
Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
|
7699729 | |
CY2022Q4 | us-gaap |
Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
|
21930000 | |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-5278244 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-8274657 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5277496 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8273909 | |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
84201446 | |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
225869764 | |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
1185903 | |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
981991 | |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1185903 | |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-981991 | |
CY2023 | us-gaap |
Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
|
7770553 | |
CY2022 | us-gaap |
Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
|
3591808 | |
CY2022 | gaq |
Transaction Costs Allocable To Warrants
TransactionCostsAllocableToWarrants
|
-1004142 | |
CY2023 | gaq |
Gain Loss From Debt Forgiven
GainLossFromDebtForgiven
|
126472 | |
CY2023 | gaq |
Unrealized Gain On Fair Value Changes Of Warrants
UnrealizedGainOnFairValueChangesOfWarrants
|
256816 | |
CY2022 | gaq |
Unrealized Gain On Fair Value Changes Of Warrants
UnrealizedGainOnFairValueChangesOfWarrants
|
8181424 | |
CY2023 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
8153841 | |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
10769090 | |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
6967938 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
9787099 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-33457 | |
CY2022 | gaq |
Adjustments To Additional Paid In Capital Shares Transferred To Investor
AdjustmentsToAdditionalPaidInCapitalSharesTransferredToInvestor
|
14272 | |
CY2022 | gaq |
Adjustments To Additional Paid In Capital Excess Of Proceeds From Sale Of Private Placement Warrants Over Fair Value
AdjustmentsToAdditionalPaidInCapitalExcessOfProceedsFromSaleOfPrivatePlacementWarrantsOverFairValue
|
3763290 | |
CY2022 | gaq |
Adjustments To Additional Paid In Capital Incentives To Anchor Investors
AdjustmentsToAdditionalPaidInCapitalIncentivesToAnchorInvestors
|
10290473 | |
CY2022 | gaq |
Adjustments To Additional Paid In Capital Re Measurement Of Carrying Value To Redemption Value
AdjustmentsToAdditionalPaidInCapitalReMeasurementOfCarryingValueToRedemptionValue
|
-32095586 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
9787099 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8273909 | |
CY2023 | gaq |
Adjustments To Additional Paid In Capital Re Measurement Of Carrying Value To Redemption Value
AdjustmentsToAdditionalPaidInCapitalReMeasurementOfCarryingValueToRedemptionValue
|
-8520553 | |
CY2023 | gaq |
Adjustments To Additional Paid In Capital Forgiven Of Deferred Underwriter Commissions
AdjustmentsToAdditionalPaidInCapitalForgivenOfDeferredUnderwriterCommissions
|
4549028 | |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
6967938 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5277496 | |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
6967938 | |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
9787099 | |
CY2023 | gaq |
Interest Earned On Investment Held In Trust Account
InterestEarnedOnInvestmentHeldInTrustAccount
|
7770553 | |
CY2022 | gaq |
Interest Earned On Investment Held In Trust Account
InterestEarnedOnInvestmentHeldInTrustAccount
|
3591808 | |
CY2022 | gaq |
Transaction Costs Incurred In Connection With Initial Public Offering
TransactionCostsIncurredInConnectionWithInitialPublicOffering
|
1004142 | |
CY2023 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-256816 | |
CY2022 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-8181424 | |
CY2023 | gaq |
Gain Loss From Debt Forgiven
GainLossFromDebtForgiven
|
126472 | |
CY2023 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-470394 | |
CY2022 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
496875 | |
CY2023 | gaq |
Increase Decrease In Accrued Offering Costs And Expenses
IncreaseDecreaseInAccruedOfferingCostsAndExpenses
|
82955 | |
CY2022 | gaq |
Increase Decrease In Accrued Offering Costs And Expenses
IncreaseDecreaseInAccruedOfferingCostsAndExpenses
|
-710905 | |
CY2023 | us-gaap |
Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
|
-85383 | |
CY2022 | us-gaap |
Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
|
69767 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-717937 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2120004 | |
CY2023 | gaq |
Payments To Acquire Investments Held In Trust Account
PaymentsToAcquireInvestmentsHeldInTrustAccount
|
458877047 | |
CY2022 | gaq |
Payments To Acquire Investments Held In Trust Account
PaymentsToAcquireInvestmentsHeldInTrustAccount
|
888533773 | |
CY2023 | gaq |
Proceeds From Disposal Of Investments Held In Trust Account
ProceedsFromDisposalOfInvestmentsHeldInTrustAccount
|
608627587 | |
CY2022 | gaq |
Proceeds From Disposal Of Investments Held In Trust Account
ProceedsFromDisposalOfInvestmentsHeldInTrustAccount
|
667041000 | |
CY2023 | gaq |
Payment To Cash Deposited In Trust Account
PaymentToCashDepositedInTrustAccount
|
750000 | |
CY2022 | gaq |
Payment To Cash Deposited In Trust Account
PaymentToCashDepositedInTrustAccount
|
227 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
149000540 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-221493000 | |
CY2022 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
216894000 | |
CY2022 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
7379000 | |
CY2022 | gaq |
Proceeds From Anchor Investor
ProceedsFromAnchorInvestor
|
14272 | |
CY2023 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
1500000 | |
CY2022 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
275000 | |
CY2022 | gaq |
Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
|
243099 | |
CY2023 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
149750540 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-148250540 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
223769173 | |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
32063 | |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
156169 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
288081 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
131912 | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
320144 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
288081 | |
CY2023 | gaq |
Waiver Of Deferred Underwriting Commissions
WaiverOfDeferredUnderwritingCommissions
|
4549028 | |
CY2022 | gaq |
Deferred Underwriting Commissions Charged To Additional Paid In Capital
DeferredUnderwritingCommissionsChargedToAdditionalPaidInCapital
|
7675500 | |
CY2022 | gaq |
Initial Value Of Stock Subject To Possible Redemption
InitialValueOfStockSubjectToPossibleRedemption
|
192989222 | |
CY2023 | gaq |
Re Measurement Of Carrying Value Of Shares Subject To Possible Redemption To Redemption Value
ReMeasurementOfCarryingValueOfSharesSubjectToPossibleRedemptionToRedemptionValue
|
8520553 | |
CY2022 | gaq |
Re Measurement Of Carrying Value Of Shares Subject To Possible Redemption To Redemption Value
ReMeasurementOfCarryingValueOfSharesSubjectToPossibleRedemptionToRedemptionValue
|
32095586 | |
CY2022 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
8988560 | |
CY2022 | gaq |
Incentive To Anchor Investors In Noncash Transactions
IncentiveToAnchorInvestorsInNoncashTransactions
|
10290473 | |
CY2023Q2 | gaq |
Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
|
4675500 | |
CY2023 | gaq |
Redemption Percentage Of Public Shares
RedemptionPercentageOfPublicShares
|
1 | |
CY2023 | gaq |
Amount Of Interest To Pay Dissolution Expenses
AmountOfInterestToPayDissolutionExpenses
|
100000 | |
CY2023Q4 | gaq |
Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
|
10.1 | |
CY2023 | gaq |
Redemption Percentage Of Public Shares
RedemptionPercentageOfPublicShares
|
1 | |
CY2023 | gaq |
Amount Of Interest To Pay Dissolution Expenses
AmountOfInterestToPayDissolutionExpenses
|
100000 | |
CY2023Q4 | gaq |
Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
|
10.1 | |
CY2023 | gaq |
Redemption Percentage Of Public Shares
RedemptionPercentageOfPublicShares
|
1 | |
CY2023Q4 | gaq |
Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
|
10.1 | |
CY2023Q4 | gaq |
Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
|
10.1 | |
CY2023Q4 | gaq |
Amount In Trust Account Per Public Share
AmountInTrustAccountPerPublicShare
|
10.1 | |
CY2023Q3 | gaq |
Business Combination Deposit To Trust Account By Related Parties
BusinessCombinationDepositToTrustAccountByRelatedParties
|
723690 | |
CY2023Q3 | us-gaap |
Share Price
SharePrice
|
0.03 | |
CY2023Q3 | gaq |
Business Combination Deposit To Trust Account By Related Parties
BusinessCombinationDepositToTrustAccountByRelatedParties
|
125000 | |
CY2023Q3 | gaq |
Business Combination Aggregate Deposit To Trust Account By Related Parties
BusinessCombinationAggregateDepositToTrustAccountByRelatedParties
|
1125000 | |
CY2023Q4 | us-gaap |
Cash
Cash
|
320144 | |
CY2023Q4 | gaq |
Working Capital Deficit
WorkingCapitalDeficit
|
1720456 | |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="margin-left:2.627%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability and over-allotment liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.</span></p> | |
CY2023 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">250,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company has not experienced losses on this account.</span></p> | |
CY2023Q4 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | |
CY2023Q4 | us-gaap |
Cash
Cash
|
320144 | |
CY2022Q4 | us-gaap |
Cash
Cash
|
288081 | |
CY2023Q2 | gaq |
Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
|
4675500 | |
CY2023Q2 | gaq |
Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
|
4675500 | |
CY2023Q3 | gaq |
Temporary Equity Redeemed During Period Value
TemporaryEquityRedeemedDuringPeriodValue
|
149750000 | |
CY2023Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2023Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2023Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
CY2023Q4 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
0 | |
CY2022Q4 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
0 | |
CY2023Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
27801 | |
CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
113184 | |
CY2022Q1 | us-gaap |
Payment For Administrative Fees
PaymentForAdministrativeFees
|
10000 | |
CY2022Q1 | gaq |
Gross Proceeds From Over Allotment Option
GrossProceedsFromOverAllotmentOption
|
19300000 | |
CY2023Q2 | gaq |
Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
|
4675500 | |
CY2023Q4 | gaq |
Remaining Deferred Underwriting Commissions
RemainingDeferredUnderwritingCommissions
|
3000000 | |
CY2023Q4 | gaq |
Payable To Underwriter In Cash
PayableToUnderwriterInCash
|
1000000 | |
CY2023Q4 | gaq |
Payable To Underwriter In Share
PayableToUnderwriterInShare
|
200000 | |
CY2023Q4 | gaq |
Nominal Value Price Per Share
NominalValuePricePerShare
|
10 | |
CY2023Q4 | gaq |
Aggregate Nominal Value
AggregateNominalValue
|
2000000 | |
CY2023Q2 | gaq |
Waived Deferred Underwriting Commissions
WaivedDeferredUnderwritingCommissions
|
4675500 | |
CY2023Q4 | gaq |
Deferred Underwriting Commissions
DeferredUnderwritingCommissions
|
3000000 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2023Q4 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
83854821 | |
CY2023Q4 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
550320 | |
CY2022Q4 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
225084808 | |
CY2022Q4 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
807136 | |
CY2023 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
|
0 | |
CY2023 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
|
0 |